 Home > Biochemistry News > Biotechnology News > Significantly reduce liver fibrosis mRNA therapy shows therapeutic potential

Significantly reduce liver fibrosis mRNA therapy shows therapeutic potential

 Last Update: 2021-09-13
 Source: Internet
 Author: User

Tags

research technology

what liver toxicity

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, CureVac announced that the company’s preclinical study of its mRNA therapy encoding hepatocyte nuclear factor 4α (HNF4A) was published in the peer-reviewed Journal of Hepatology
.

It is reported that this study provides preclinical data for the first time, proving the applicability of mRNA therapy encoding HNF4A transcription factor in the treatment of liver fibrosis and cirrhosis

Liver fibrosis is characterized by the formation of scar tissue in the liver, which causes gradual impairment of liver function
.

This process can evolve into irreversible advanced liver cirrhosis, leading to liver failure or cancer

The research was conducted jointly by the company's researchers and experts from Hannover Medical School in Germany
.

In this study, the researchers used lipid nanoparticles (LNP) to deliver mRNA therapy encoding HNF4A in 4 independent mouse models of liver disease

▲Research icon (picture source: reference [2])

Reference materials:

[1] CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic.

[2] Yang et al.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.